AbbVie Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	59,644	56,334	54,318	58,054	56,197	45,804
Revenue Growth (YoY)	7.40%	3.71%	-6.44%	3.30%	22.69%	37.69%
Cost of Revenue	17,022	16,689	16,726	16,527	17,314	15,257
Gross Profit	42,622	39,645	37,592	41,527	38,883	30,547
Selling, General & Admin	12,601	13,189	12,904	14,584	11,872	9,867
Research & Development	8,787	8,131	7,038	6,487	6,820	6,003
Other Operating Expenses	-31	-7	-10	228	432	-
Operating Expenses	21,357	21,313	19,932	21,299	19,124	15,870
Operating Income	21,265	18,332	17,660	20,228	19,759	14,677
Interest Expense	-2,881	-2,808	-2,224	-2,230	-2,423	-2,454
Interest & Investment Income	299	648	540	186	39	174
Currency Exchange Gain (Loss)	-66	-21	-146	-148	-51	-71
Other Non Operating Income (Expenses)	346	271	190	142	55	113
EBT Excluding Unusual Items	18,963	16,422	16,020	18,178	17,379	12,439
Merger & Restructuring Charges	-377	-792	-119	-539	-587	-1,912
Gain (Loss) on Sale of Assets	-	-	-	172	-	-
Asset Writedown	-5,323	-4,476	-4,230	-876	-	-
Legal Settlements	-910	-910	485	-	-	-
Other Unusual Items	-5,368	-3,771	-5,128	-2,761	-2,679	-5,753
Pretax Income	1,660	3,716	6,250	13,477	12,989	3,398
Income Tax Expense	-735	-570	1,377	1,632	1,440	-1,224
Earnings From Continuing Operations	2,395	4,286	4,873	11,845	11,549	4,622
Minority Interest in Earnings	-7	-8	-10	-9	-7	-6
Net Income	2,388	4,278	4,863	11,836	11,542	4,616
Preferred Dividends & Other Adjustments	40	40	43	54	74	60
Net Income to Common	2,348	4,238	4,820	11,782	11,468	4,556
Net Income Growth	-53.38%	-12.03%	-58.91%	2.55%	150.04%	-41.44%
Shares Outstanding (Basic)	1,769	1,769	1,768	1,771	1,770	1,667
Shares Outstanding (Diluted)	1,773	1,773	1,773	1,778	1,777	1,673
Shares Change (YoY)	-	-	-0.28%	0.06%	6.22%	12.74%
EPS (Basic)	1.33	2.40	2.73	6.65	6.48	2.73
EPS (Diluted)	1.32	2.39	2.72	6.63	6.45	2.72
EPS Growth	-53.99%	-12.13%	-58.97%	2.79%	137.13%	-48.48%
Free Cash Flow	19,684	17,832	22,062	24,248	21,990	16,790
Free Cash Flow Per Share	11.10	10.06	12.44	13.64	12.38	10.04
Dividend Per Share	6.560	6.290	5.990	5.710	5.310	4.840
Dividend Growth	5.81%	5.01%	4.90%	7.53%	9.71%	10.25%
Gross Margin	71.46%	70.38%	69.21%	71.53%	69.19%	66.69%
Operating Margin	35.65%	32.54%	32.51%	34.84%	35.16%	32.04%
Profit Margin	3.94%	7.52%	8.87%	20.29%	20.41%	9.95%
Free Cash Flow Margin	33.00%	31.65%	40.62%	41.77%	39.13%	36.66%
EBITDA	29,519	26,718	26,358	28,695	28,280	21,148
EBITDA Margin	49.49%	47.43%	48.52%	49.43%	50.32%	46.17%
D&A For EBITDA	8,254	8,386	8,698	8,467	8,521	6,471
EBIT	21,265	18,332	17,660	20,228	19,759	14,677
EBIT Margin	35.65%	32.54%	32.51%	34.84%	35.16%	32.04%
Effective Tax Rate	-	-	22.03%	12.11%	11.09%	-
Advertising Expenses	-	2,100	2,200	2,000	2,100	1,800

Source: S&P Global Market Intelligence. Standard template. Financial Sources.